Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02932098 · ClinicalTrials.gov registry record · NA
Post-Operative Gynecological Oncology App Study
A NA study of Genital Neoplasm, Female, sponsored by University of Tennessee.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 3
- Study locations
NCT02932098 is a NA study of Genital Neoplasm, Female that has completed, run by University of Tennessee. The registered enrollment target is 22 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT02932098, a NA study of Genital Neoplasm, Female, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 3
- Study locations
Study Summary
Purpose: The purpose of this study will be to test the use of a web-based mobile application (app) initiated at the time of hospital discharge to engage and monitor patients in order to efficiently deliver better outcomes. The mobile app will be used to remind patients of discharge instructions, assess adherence treatment regimens, and evaluate symptoms. Rationale: Approximately 60% of patients with ovarian cancer have advanced stage disease at diagnosis, and thus aggressive surgical procedures are often medically necessary. Recent evidence suggests that nearly one in five patients hospitalized for ovarian cancer surgery will be readmitted within 30 days of discharge. Patients readmitted within 30 days have a 50% increase in one-year mortality rates and significantly increased costs of care. In addition, many of the conditions and complications that led to readmission could potentially have been avoided with more intensive post-surgical follow-up care. Mobile health technologies can effectively and efficiently connect patients with their healthcare team and have been shown to improve treatment adherence and reduce avoidable ER visits and hospitalizations.
Conditions Studied
Interventions
- BEHAVIORAL Clinical Alerts
- BEHAVIORAL Discharge instructions reminders
- BEHAVIORAL Prompts to report symptoms via the web-enabled app
Study Locations (3)
Tennessee
- West Cancer Center, MIDTOWN, 1588 Union Ave. - Memphis
- West Cancer Center, EAST MEMPHIS, 7945 Wolf River Blvd - Memphis
Mississippi
- West Cancer Center, DESOTO, 7668 Airways Blvd. - Southaven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-08 |
| Est. Completion | 2018-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02932098
The ClinicalTrials.gov registry entry for NCT02932098 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Genital Neoplasm, Female appearing as the primary indexed condition, and to 3 interventions - of which Clinical Alerts is the first listed.
NCT02932098 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Tennessee, Mississippi.
Frequently Asked Questions
What is clinical trial NCT02932098 about?
NCT02932098 is a clinical study titled "Post-Operative Gynecological Oncology App Study". Purpose: The purpose of this study will be to test the use of a web-based mobile application (app) initiated at the time of hospital discharge to engage and monitor patients in order to efficiently deliver better outcomes. The mobile app will be used to remind patients of discharge instructions, ass...
What is the current status of trial NCT02932098?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-08. Estimated completion is 2018-03.
What conditions does trial NCT02932098 study?
This clinical trial studies the following conditions: Genital Neoplasm, Female.
What interventions are being tested in trial NCT02932098?
The interventions under investigation include: Clinical Alerts (BEHAVIORAL), Discharge instructions reminders (BEHAVIORAL), Prompts to report symptoms via the web-enabled app (BEHAVIORAL).
Who is sponsoring clinical trial NCT02932098?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02932098 being conducted?
This trial has 3 study locations across Mississippi, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genital Neoplasm, Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.